@article{c5632097c912431cab82e60b2f382d39,
title = "Clinical findings of 21 previously unreported probands with HNRNPU-related syndrome and comprehensive literature review",
abstract = "With advances in genetic testing and improved access to such advances, whole exome sequencing is becoming a first-line investigation in clinical work-up of children with developmental delay/intellectual disability (ID). As a result, the need to understand the importance of genetic variants and its effect on the clinical phenotype is increasing. Here, we report on the largest cohort of patients with HNRNPU variants. These 21 patients follow on from the previous study published by Yates et al. in 2017 from our group predominantly identified from the Deciphering Developmental Disorders study that reported seven patients with HNRNPU variants. All the probands reported here have a de novo loss-of-function variant. These probands have craniofacial dysmorphic features, in the majority including widely spaced teeth, microcephaly, high arched eyebrows, and palpebral fissure abnormalities. Many of the patients in the group also have moderate to severe ID and seizures that tend to start in early childhood. This series has allowed us to define a novel neurodevelopmental syndrome, with a likely mechanism of haploinsufficiency, and expand substantially on already published literature on HNRNPU-related neurodevelopmental syndrome.",
keywords = "DDD study, exome sequencing, HNRNPU, intellectual disability, seizures",
author = "Anna Durkin and Shadi Albaba and Fry, {Andrew E.} and Morton, {Jenny E.} and Andrew Douglas and Ana Beleza and Denise Williams and Volker-Touw, {Catharina M.L.} and Lynch, {Sally A.} and Natalie Canham and Virginia Clowes and Volker Straub and Katherine Lachlan and Frances Gibbon and {El Gamal}, Mayy and Vinod Varghese and Parker, {Michael J.} and Ruth Newbury-Ecob and Turnpenny, {Peter D.} and Alice Gardham and Neeti Ghali and Meena Balasubramanian",
note = "Funding Information: The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (Grant No. HICF‐1009‐003). This study makes use of DECIPHER ( http://decipher.sanger.ac.uk ), which is funded by the Wellcome. See PMID: 25533962 or www.ddduk.org/access.html for full acknowledgement. We would also like to thank all the families for consenting to this publication. Nature Funding Information: The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (Grant No. HICF-1009-003). This study makes use of DECIPHER (http://decipher.sanger.ac.uk), which is funded by the Wellcome. See Nature PMID: 25533962 or www.ddduk.org/access.html for full acknowledgement. We would also like to thank all the families for consenting to this publication. Publisher Copyright: {\textcopyright} 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.",
year = "2020",
month = jul,
day = "1",
doi = "10.1002/ajmg.a.61599",
language = "English",
volume = "182",
pages = "1637--1654",
journal = "American Journal of Medical Genetics. Part A",
issn = "1552-4825",
publisher = "John Wiley & Sons Inc.",
number = "7",
}